Genomic Health (GHDX) Tops Q2 EPS by 17c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q2 EPS of $0.23, $0.17 better than the analyst estimate of $0.06. Revenue for the quarter came in at $95.6 million versus the consensus estimate of $92.11 million.
GUIDANCE:
Genomic Health sees FY2018 EPS of $0.39-$0.56, versus the consensus of $0.45. Genomic Health sees FY2018 revenue of $366-382 million, versus the consensus of $377.07 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- National CineMedia (NCMI) Misses Q2 EPS by 7c
- Integra Resources (ITRG) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
